ArriVent BioPharma, Inc. SEC filings AVBP
ArriVent BioPharma, Inc. has 160 filings in SEC EDGAR's recent list, going back to Jun 23, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Jan 26, 2024 | — |
| EFFECT | Filing | Jan 25, 2024 | — |
| CERT | Filing | Jan 25, 2024 | — |
| 8-A12B | Filing | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2024 | — |
| CORRESP | Letter to the SEC | Jan 11, 2024 | — |
| DRS/A | Filing | Dec 6, 2023 | — |
| DRSLTR | Filing | Dec 5, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| DRSLTR | Filing | Oct 31, 2023 | — |
| DRS/A | Filing | Oct 31, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 13, 2023 | — |
| DRSLTR | Filing | Oct 4, 2023 | — |
| DRS/A | Filing | Oct 4, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| DRS | Filing | Aug 25, 2023 | — |
| D | Filing | Dec 29, 2022 | — |
| D/A | Filing | Feb 14, 2022 | — |
| D | Filing | Jun 23, 2021 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newtown Square, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1868279
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.